KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Rigel Pharmaceuticals (RIGL) Other Gross PP&E Adjustments (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 15 years of Other Gross PP&E Adjustments data on record, last reported at -$573000.0 in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 635.51% year-over-year to -$573000.0; the TTM value through Dec 2025 reached -$573000.0, down 635.51%, while the annual FY2025 figure was -$573000.0, 635.51% down from the prior year.
  • Other Gross PP&E Adjustments reached -$573000.0 in Q4 2025 per RIGL's latest filing, up from -$1.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $9.7 million in Q4 2022 and bottomed at -$15.9 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$2.4 million, with a median of -$1.0 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 366.72% in 2021, then plummeted 635.51% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $6.8 million in 2021, then skyrocketed by 42.56% to $9.7 million in 2022, then tumbled by 89.64% to $1.0 million in 2023, then crashed by 89.38% to $107000.0 in 2024, then tumbled by 635.51% to -$573000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$573000.0 in Q4 2025, -$1.0 million in Q3 2025, and -$1.2 million in Q2 2025.